Corydon T J, Bross P, Jensen T G, Corydon M J, Lund T B, Jensen U B, Kim J J, Gregersen N, Bolund L
Institute of Human Genetics, Wilhelm Meyers Allé, Aarhus University, DK-8000 Aarhus C, Denmark.
J Biol Chem. 1998 May 22;273(21):13065-71. doi: 10.1074/jbc.273.21.13065.
Most disease-causing missense mutations in short-chain acyl-CoA dehydrogenase (SCAD) and medium-chain acyl-CoA dehydrogenase are thought to compromise the mitochondrial folding and/or stability of the mutant proteins. To address this question, we studied the biogenesis of SCAD proteins in COS-7 cells transfected with cDNA corresponding to two SCAD missense mutations, R22W (identified in a patient with SCAD deficiency) or R22C (homologous to a disease-associated R28C mutation in medium-chain acyl-CoA dehydrogenase deficiency). After cultivation at 37 degreesC the steady-state amounts of SCAD antigen and activity in extracts from cells transfected with mutant SCAD cDNAs were negligible compared with those of cells transfected with SCAD wild type cDNA, documenting the deleterious effect of the two mutations. Analysis of metabolically labeled and immunoprecipitated SCAD wild type and mutant proteins showed that the two mutant proteins were synthesized as the 44-kDa precursor form, imported into mitochondria and processed to the mature 41.7-kDa form in a normal fashion. However, the intramitochondrial level of matured mutant SCAD proteins decreased rapidly to very low levels, indicating a rapid degradation of the mutant proteins at 37 degreesC. A rapid initial elimination phase was also observed following cultivation at 26 degreesC; however, significantly higher amounts of metabolically labeled and immunoprecipitated mature mutant SCAD proteins remained detectable. This corresponds well with the appreciable steady-state levels of SCAD mutant enzyme activity observed at 26 degreesC. In addition, confocal laser scanning microscopy of immunostained cells showed that the SCAD mutant proteins were localized intramitochondrially. Together, these results show that newly synthesized SCAD R22W and R22C mutant proteins are imported and processed in the mitochondrial matrix, but that a fraction of the proteins is rapidly eliminated by a temperature-dependent degradation mechanism. Thermal stability profiles of wild type and mutant enzymes revealed no difference between the two mutants and the wild type protein. Furthermore, the turnover of the SCAD mutant enzymes in intact cells was comparable to that of the wild type, indicating that the rapid degradation of the mutant SCAD proteins is not due to lability of the correctly folded tetrameric structure but rather to elimination of partly folded or misfolded proteins along the folding pathway.
短链酰基辅酶A脱氢酶(SCAD)和中链酰基辅酶A脱氢酶中大多数致病的错义突变被认为会损害突变蛋白的线粒体折叠和/或稳定性。为了解决这个问题,我们研究了用对应于两种SCAD错义突变(R22W,在一名SCAD缺乏症患者中鉴定出;或R22C,与中链酰基辅酶A脱氢酶缺乏症中与疾病相关的R28C突变同源)的cDNA转染的COS-7细胞中SCAD蛋白的生物合成。在37℃培养后,与用SCAD野生型cDNA转染的细胞相比,用突变型SCAD cDNA转染的细胞提取物中SCAD抗原和活性的稳态量可以忽略不计,这证明了这两种突变的有害作用。对代谢标记和免疫沉淀的SCAD野生型和突变型蛋白的分析表明,这两种突变型蛋白以44 kDa的前体形式合成,导入线粒体并正常加工成成熟的41.7 kDa形式。然而,成熟的突变型SCAD蛋白的线粒体内水平迅速下降到非常低的水平,表明突变型蛋白在37℃下迅速降解。在26℃培养后也观察到快速的初始消除阶段;然而,仍可检测到显著更高量的代谢标记和免疫沉淀的成熟突变型SCAD蛋白。这与在26℃观察到的SCAD突变酶活性的可观稳态水平很好地对应。此外,对免疫染色细胞的共聚焦激光扫描显微镜检查表明,SCAD突变蛋白定位于线粒体内。总之,这些结果表明,新合成的SCAD R22W和R22C突变蛋白在线粒体基质中被导入和加工,但一部分蛋白通过温度依赖性降解机制被迅速消除。野生型和突变型酶的热稳定性曲线显示这两种突变体与野生型蛋白之间没有差异。此外,完整细胞中SCAD突变酶的周转与野生型相当,表明突变型SCAD蛋白的快速降解不是由于正确折叠的四聚体结构的不稳定性,而是由于沿着折叠途径消除部分折叠或错误折叠的蛋白。